- Home
- HITI vs TVGN Comparison
HITI vs TVGN Comparison
Compare HITI & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HITI
- TVGN
- Stock Information
- Founded
- HITI 2009
- TVGN 2020
- Country
- HITI Canada
- TVGN United States
- Employees
- HITI N/A
- TVGN N/A
- Industry
- HITI
- TVGN Blank Checks
- Sector
- HITI
- TVGN Finance
- Exchange
- HITI Nasdaq
- TVGN Nasdaq
- Market Cap
- HITI 219.4M
- TVGN 174.4M
- IPO Year
- HITI N/A
- TVGN N/A
- Fundamental
- Price
- HITI $2.84
- TVGN $1.43
- Analyst Decision
- HITI Strong Buy
- TVGN
- Analyst Count
- HITI 1
- TVGN 0
- Target Price
- HITI $4.50
- TVGN N/A
- AVG Volume (30 Days)
- HITI 731.4K
- TVGN 4.9M
- Earning Date
- HITI 01-29-2025
- TVGN 02-20-2025
- Dividend Yield
- HITI N/A
- TVGN N/A
- EPS Growth
- HITI N/A
- TVGN N/A
- EPS
- HITI N/A
- TVGN N/A
- Revenue
- HITI $374,815,931.00
- TVGN N/A
- Revenue This Year
- HITI $14.48
- TVGN N/A
- Revenue Next Year
- HITI $16.50
- TVGN N/A
- P/E Ratio
- HITI N/A
- TVGN N/A
- Revenue Growth
- HITI 7.10
- TVGN N/A
- 52 Week Low
- HITI $1.57
- TVGN $0.26
- 52 Week High
- HITI $3.62
- TVGN $21.09
- Technical
- Relative Strength Index (RSI)
- HITI 35.52
- TVGN 54.34
- Support Level
- HITI $2.60
- TVGN $1.30
- Resistance Level
- HITI $2.96
- TVGN $1.54
- Average True Range (ATR)
- HITI 0.15
- TVGN 0.17
- MACD
- HITI -0.04
- TVGN 0.01
- Stochastic Oscillator
- HITI 9.52
- TVGN 35.14
About HITI High Tide Inc.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically-integrated company in the Canadian cannabis market with portfolio subsidiaries including RGR Canada Inc., Famous Brandz Inc., Kush West Distribution Inc., Smoker's Corner Ltd., Grasscity.com, Canna Cabana Inc., and KushBar Inc. The firm has established two main segments, retail and wholesale. It generates substantial revenue from retail stores' e-commerce platforms. Geographically it serves Canada, the USA, and other international markets and earns key revenue from domestic sales.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.